Plasma S100A12 concentrations in peritoneal dialysis patients and subclinical chronic inflammatory disease

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 1, 2008, Pages 28-32

  Uchiyama Tanaka, Yoko ^a,e   Mori, Yasukiyo ^a   Kosaki, Atsushi ^b   Kimura, Tatsuji ^c   Moriishi, Misaki ^d   Kawanishi, Hideki ^d   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c FUJIREBIO INC   (Japan)

^d TSUCHIYA GENERAL HOSPITAL   (Japan)

^e Kanda Clinic   (Japan)

Author keywords

Advanced glycation end products; Atherosclerosis; Peritoneal dialysis; Peritoneal transport; S100A12

Indexed keywords

PROTEIN S 100; PROTEIN S100A12; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL MIGRATION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

ADULT; BIOLOGICAL TRANSPORT; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEAL DISEASES; S100 PROTEINS; SCLEROSIS;

EID: 38849186615     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00537.x     Document Type: Article

References (23)

1. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984 101 : 527 37.
2. Heidland A, Sebekova K, Schinzel R. Advanced glycation end products and the progressive course of renal disease. Am J Kidney Dis 2001 38 : S100 6.
3. Huang JS, Guh JY, Chen HC, Hung WC, Lai YH, Chuang LY. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem 2001 81 : 102 13.
4. Hofmann MA, Drury S, Fu C et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999 97 : 889 901.
5. Moroz OV, Dodson GG, Wilson KS, Lukanidin E, Bronstein IB. Multiple structural states of S100A12: key to its functional diversity. Microsc Res Tech 2003 60 : 581 92.
6. Yang Z, Tao T, Raftery MJ, Youssef P, Di Girolamo N, Geczy CL. Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol 2001 69 : 986 94.
7. Foell D, Ichida F, Vogl T et al. S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet 2003 361 : 1270 2.
8. Foell D, Kane D, Bresnihan B et al. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 2003 42 : 1383 9.
9. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001 286 : 327 34.
10. Zinman B, Hanley AJ, Harris SB, Kwan J, Fantus IG. Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab 1999 84 : 272 8.
11. Kosaki A, Hasegawa T, Kimura T et al. Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2004 89 : 5423 8.
12. Yamamura T, Hitomi J, Nagasaki K et al. Human CAAF1 gene - molecular cloning, gene structure, and chromosome mapping. Biochemi Biophys Res Commun 1996 221 : 356 60.
13. Twardowski ZJ. PET - a simpler approach for determining prescriptions for adequate dialysis therapy. Adv Perit Dial 1990 6 : 186 91.
14. Hung KY, Huang JW, Tsai TJ, Chen WY. Natural changes in peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients: a retrospective, seven year cohort survey. Artif Organs 2000 24 : 261 4.
15. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998 9 : 1285 92.
16. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999 340 : 115 26.
17. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997 272 : 9496 502.
18. Wendt T, Tanji N, Guo J et al. Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy. J Am Soc Nephrol 2003 14 : 1383 95.
19. Hasegawa T, Kosaki A, Kimura T et al. The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages. Atherosclerosis 2003 171 : 211 18.
20. Kislinger T, Tanji N, Wendt T et al. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2001 21 : 905 10.
21. Nakamoto H, Kawaguchi Y, Suzuki H. Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan. Adv Perit Dial 2002 18 : 119 23.
22. Pecoits-Filho R, Araujo MR, Lindholm B et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002 17 : 1480 6.
23. Numata M, Nakayama M, Hosoya T et al. Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients. Clin Nephrol 2004 62 : 455 60.